Recall of Daily Shield hand sanitizer expanded, Bio Life licence suspended
Found to contain less than the recommended amount of ethanol, decreases the product’s effectiveness at killing bacteria and viruses.
Health Canada now to review applications for COVID-19 home tests
Reversal because official “misspoke” in confirming applications for home testing kits would not be reviewed.
Urban Juve gets approval for a second hand sanitizer to battle COVID-19
Hand cleaner from Vancouver developer of plant-based skin products fast-tracked by Health Canada.
Health Canada warns against fraudulent, unauthorized N95 masks
Uncertified N95 respirator masks are being illegally sold online and in some stores.
CannTrust to destroy $77M of cannabis to comply with rules
$12 million of biological assets and about $65 million of inventory not authorized by CannTrust’s licence.
Flu vaccine delays as season starts, manufacturing shortage blamed
Agency says 55% of the total vaccine order is currently available to be distributed across the country.
Canadian doctor says blowback to meat study is ‘hysterical’
Found evidence linking red meat consumption to cancer, heart disease and other bad health outcomes is weak.
Returned CannTrust products by Alberta wholesaler worth $1.3M
Follows Health Canada’s suspension of pot company’s licences to produce and sell pot.
Alberta to return CannTrust pot after Health Canada suspensions
Pot products producer’s authority to produce and sell cannabis had been suspended.
OSC approves management cease trade order at CannTrust Holdings
Cannabis company waiting on timing and impact of Health Canada’s decisions regarding non-compliance with regulatory requirements.
CannTrust says Health Canada rated Vaughan cannabis facility non-compliant
Decision based on an inspection in July following revelations a greenhouse in Pelham was non-compliant.
CannTrust hires adviser to explore sale amid unlicensed pot growing probe
Alternatives a sale of the company or a portion of it, a merger, a strategic investment, or changes to its operations.
Pot-based medical pet products closer to fruition as research grows
Canopy Growth embarking on a Health Canada-approved clinical trial using cannabis-based products to treat animal anxiety.
